Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00709878 · ClinicalTrials.gov registry record
Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors
A clinical trial of Skin Rash, sponsored by Northwestern University.
- Completed
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT00709878: Completed study of Skin Rash, sponsored by Northwestern University.
NCT00709878 is a study of Skin Rash that has completed, run by Northwestern University. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00709878, a study of Skin Rash, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize the microscopic findings of skin rash associated with the use of chemotherapeutic anticancer agents known as epidermal growth factor inhibitors (EGFRIs).
Conditions Studied
Interventions
- PROCEDURE Skin Biopsy of Skin Rash Secondary to EGFRI Use
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-08 |
What the finished NCT00709878 record still lists
NCT00709878 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 1 condition, with Skin Rash appearing as the primary indexed condition, and to 1 intervention - of which Skin Biopsy of Skin Rash Secondary to EGFRI Use is the first listed.
NCT00709878 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00709878 about?
NCT00709878 is a clinical study titled "Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors". The purpose of this study is to characterize the microscopic findings of skin rash associated with the use of chemotherapeutic anticancer agents known as epidermal growth factor inhibitors (EGFRIs).
What is the current status of trial NCT00709878?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2008-04. Estimated completion is 2010-08.
What conditions does trial NCT00709878 study?
This clinical trial studies the following conditions: Skin Rash.
What interventions are being tested in trial NCT00709878?
The interventions under investigation include: Skin Biopsy of Skin Rash Secondary to EGFRI Use (PROCEDURE).
Who is sponsoring clinical trial NCT00709878?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00709878 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia